FRANCISCO
GAVILANES FRANCO
Investigador ata 2020
Centro Nacional de Biotecnología
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro Nacional de Biotecnología (9)
2008
-
Insights into the oligomerization state-helicase activity relationship of West Nile virus NS3 NTPase/helicase
Virus Research, Vol. 135, Núm. 1, pp. 166-174
2006
-
Influence of acylation of a peptide corresponding to the amino-terminal region of endothelial nitric oxide synthase on the interaction with model membranes
Biochemistry, Vol. 45, Núm. 4, pp. 1263-1270
-
Membrane-perturbing properties of three peptides corresponding to the ectodomain of hepatitis C virus E2 envelope protein
Biochimica et Biophysica Acta - Biomembranes, Vol. 1758, Núm. 6, pp. 755-763
2005
-
Direct interaction between the reductase domain of endothelial nitric oxide synthase and the ryanodine receptor
FEBS Letters, Vol. 579, Núm. 14, pp. 3159-3163
2003
-
Probing the channel-bound Shaker B inactivating peptide by stereoisomeric substitution at a strategic tyrosine residue
Biochemistry, Vol. 42, Núm. 29, pp. 8879-8884
2002
-
Tyrosine phosphorylation of the inactivating peptide of the Shaker B potassium channel: A structural-functional correlate
Biochemistry, Vol. 41, Núm. 40, pp. 12263-12269
2001
-
Identification of novel cellular proteins that bind to the LC8 dynein light chain using a pepscan technique
FEBS Letters, Vol. 503, Núm. 2-3, pp. 135-141
2000
-
Selective destabilization of acidic phospholipid bilayers performed by the hepatitis B virus fusion peptide
Biochimica et Biophysica Acta - Biomembranes, Vol. 1463, Núm. 2, pp. 419-428
1998
-
Inactivating peptide of the Shaker B potassium channel: Conformational preferences inferred from studies on simple model systems
Biochemical Journal, Vol. 331, Núm. 2, pp. 497-504